Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Insulin therapy helped a man with autoimmune issues regrow his hair.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

VKHD and sarcoidosis may share a common cause.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A genetic marker linked to a type of hair loss was found in most patients studied.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Alopecia areata involves immune response and gene changes affecting hair loss.

Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Female hair loss can be diagnosed using specific trichoscopy criteria.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.